Global Patent Index - EP 2049150 A2

EP 2049150 A2 20090422 - RECOMBINANT OU TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS

Title (en)

RECOMBINANT OU TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS

Title (de)

REKOMBINANTE TRANSGENE OU-FAKTOR VII-VERBINDUNG MIT MEHRHEITLICHEM ANTEIL BIANTENNÄRER, BISIALYLIERTER UND NICHT FUCOSYLIERTER GLYCANFORMEN

Title (fr)

COMPOSITION DE FACTEUR VII RECOMBINANT

Publication

EP 2049150 A2 20090422 (FR)

Application

EP 07823378 A 20070731

Priority

  • FR 2007001324 W 20070731
  • FR 0607016 A 20060801

Abstract (en)

[origin: WO2008015339A2] The present invention concerns a recombinant or transgenic factor VII compound, each factor VII molecule of the compound having glycan forms linked to N-glycosylation sites, wherein among all the factor VII molecules in said compound, glycan, biantennary, bisialylated, and non-fucosylated forms are in the majority. The invention also concerns such a compound for use as a medication, and a method for preparing said compound, among others.

IPC 8 full level

A61K 38/36 (2006.01); A61K 38/48 (2006.01); C07K 14/745 (2006.01); C12P 21/00 (2006.01)

CPC (source: EP KR US)

A61K 38/36 (2013.01 - KR); A61P 7/04 (2017.12 - EP); C07K 14/745 (2013.01 - EP KR US); C12N 9/64 (2013.01 - EP US); C12N 9/6437 (2013.01 - EP US); C12N 9/647 (2013.01 - EP US); C12P 21/00 (2013.01 - KR); C12Y 304/21021 (2013.01 - EP US); A01K 2217/05 (2013.01 - EP US); A01K 2227/107 (2013.01 - EP US); A01K 2267/01 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)

Citation (search report)

See references of WO 2008015339A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

DOCDB simple family (publication)

WO 2008015339 A2 20080207; WO 2008015339 A3 20080417; AR 062162 A1 20081022; AR 103027 A2 20170412; AU 2007280330 A1 20080207; AU 2007280330 B2 20111110; BR PI0715420 A2 20130702; CA 2658800 A1 20080207; CA 2658800 C 20150331; CA 2876621 A1 20080207; CN 101495133 A 20090729; CN 103397011 A 20131120; CN 103397011 B 20161005; EP 2049150 A2 20090422; FR 2904558 A1 20080208; FR 2904558 B1 20081017; IL 196379 A0 20110801; IL 196379 A 20160421; JP 2009545575 A 20091224; JP 2015042678 A 20150305; JP 5653619 B2 20150114; KR 101233630 B1 20130218; KR 20090040892 A 20090427; TW 200825102 A 20080616; TW I391400 B 20130401; US 2009239788 A1 20090924; US 2013189244 A1 20130725

DOCDB simple family (application)

FR 2007001324 W 20070731; AR P070103379 A 20070801; AR P150104084 A 20151215; AU 2007280330 A 20070731; BR PI0715420 A 20070731; CA 2658800 A 20070731; CA 2876621 A 20070731; CN 200780027968 A 20070731; CN 201310341768 A 20070731; EP 07823378 A 20070731; FR 0607016 A 20060801; IL 19637909 A 20090107; JP 2009522304 A 20070731; JP 2014234766 A 20141119; KR 20097001954 A 20070731; TW 96128233 A 20070801; US 201213705948 A 20121205; US 37426907 A 20070731